Biotecnología
Biotecnología
Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
28/09/2023 -
Pfizer will leverage Ginkgo's RNA technology for the discovery and development of novel RNA molecules across priority research areas.
Integrated DNA Technologies, Aldevron Partner on CRISPR Components
19/09/2023 -
Integrated DNA Technologies will sell Aldevron cGMP manufactured CRISPR nucleases.
GenScript Adds Circular RNA, Lipid Nanoparticles Formulation
19/09/2023 -
Aims to offer comprehensive range of RNA formats critical, enabling fast delivery of complex design for the R&D of RNA vaccines and therapeutics.
Curia Supports Replicate Bioscience’s Phase 1 Trial of RNA Vax
14/09/2023 -
Supply of drug substance manufactured under cGMP supports clinical study for RBI-4000 novel self-replicating RNA.
Applied DNA Names Executive Director of Quality and cGMP Programs
13/09/2023 -
Beverly Wolgast will lead implementation of cGMP-quality LineaDNA Capability for IVT mRNA Production.
Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus
01/09/2023 -
Investment enhances Almac’s NGS portfolio of DNA sequencing service offerings.
Charles River, Fondazione Telethon Partner on Plasmid Manufacturing
28/08/2023 -
Charles River to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production.
AAHI Receives $18M NIH Award to Develop Chikungunya RNA Vaccine
07/08/2023 -
To develop a temperature stable, single-dose vaccine candidate for the chikungunya virus using a live “attenuated” virus.
Curia Expands Capabilities with Access to Touchlight’s Doggybone DNA
25/07/2023 -
Alliance expands Curia’s mRNA manufacturing offerings with an additional differentiated source of DNA raw material.
Korro Bio, Frequency Therapeutics Announce $117M Merger
17/07/2023 -
To create genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs.
Applied DNA Acquires RNA Polymerase Developer Spindle Biotech
17/07/2023 -
Platform enables customers to manufacture mRNA with substantial reduction in dsRNA and manufacturing complexities.
Ardena Partners with RiboPro Forge to Support the RNA Revolution
11/07/2023 -
Alliance aimed at delivering improvements to the global availability of RNA-based health treatments and address a crucial skills gap.
Elsie Biotech, GSK Partner to Accelerate Oligonucleotide Technologies
11/07/2023 -
Collaboration combines GSK's expertise in DNA encoded library technologies with Elsie's drug discovery platform.
Touchlight Expands DNA Manufacturing Facility in London
05/06/2023 -
Facility will enable commercialization of genetic medicines.
GenScript Unveils GenTitan Gene Fragments Service
05/06/2023 -
Provides access to high-throughput, synthetic DNA for studies.
Exothera, Quantoom Biosciences Partner on RNA Platform
05/05/2023 -
Exothera Nucleic Acids will be the first CDMO with access to Quantoom’s continuous production platform for RNA.
Charles River Launches Accugenix NGS for Bacterial and Fungal Identification
05/05/2023 -
Sequences millions of individual DNA fragments from a sample and offers a snapshot of the microbiome, providing key information about microbial control.
PharmaJet Announces Government Award Expansion to Clinically Assess a DNA Vaccine
25/04/2023 -
Follow-on award under a multi-year agreement with the U.S. Defense Threat Reduction Agency.
Lonza, ABL Bio Partner to Develop and Manufacture Bispecific Antibody Product
05/04/2023 -
Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate from DNA to potential investigational new drug (IND) application.
Wacker, Cordenpharma, LMU & HU Berlin Train AI Machine/Learning Algorithm
03/04/2023 -
A machine learning algorithm is to be trained that automatically identifies the best constituents for new RNA formulations.
Evonik Begins Construction of $220M U.S. Facility for Pharmaceutical Lipids
31/03/2023 -
Facility to secure global supply of functional excipients for RNA medicines.
